Journal of Surgical Oncology
-
Publication Venue For
-
Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines..
125:28-33.
2022
-
Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma..
123:381-388.
2021
-
Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients..
120:206-213.
2019
-
The optimal number of lymph nodes to evaluate among patients undergoing surgery for gallbladder cancer: Correlating the number of nodes removed with survival in 6531 patients..
119:1099-1107.
2019
-
Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review..
119:30-39.
2019
-
Safety and oncologic outcomes of robotic liver resections: A systematic review..
117:1517-1530.
2018
-
Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review..
117:341-353.
2018
-
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis..
116:643-650.
2017
-
Liver transplantation for unresectable colorectal liver metastases: A systematic review..
116:288-297.
2017
-
Non-ampullary duodenal adenocarcinoma: Factors important for relapse and survival (Journal of Surgical Oncology (2009) 100, 2, (144-148)).
100:434.
2009
-
Can surgeons improve survival in stage IV melanoma?.
97:462-468.
2008
-
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935..
94:599-606.
2006
-
The Kraske procedure: a critical analysis of a surgical approach for mid-rectal lesions..
94:194-202.
2006
-
Submucosal resection of giant gastric lipoma..
94:63-67.
2006
-
Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis: Commentary.
93:42-43.
2006
-
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab..
91:173-180.
2005
-
Mucosal melanoma..
86:187-188.
2004
-
Mitochondrial DNA alterations in thyroid cancer..
82:170-173.
2003
-
Heterotopic ossification in rectal cancer: Rare finding with a novel proposed mechanism..
82:132-136.
2003
-
Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection..
78:162-170.
2001
-
FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume..
77:237-242.
2001
-
Recurrent ductal carcinoma in situ after total mastectomy..
71:182-185.
1999
-
MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases..
71:36-45.
1999
-
Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice..
68:79-91.
1998
-
Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis..
66:230-236.
1997
-
Primary malignant melanoma of the esophagus..
66:201-206.
1997
-
Appendiceal carcinoma: patterns of failure following surgery and implications for adjuvant therapy..
66:51-53.
1997
-
Interlaboratory variation in oxygen tension measurement by Eppendorf "Histograph" and comparison with hypoxic marker..
66:30-38.
1997
-
Prognostic factors for fibromatoses: a correlation of proliferation index, estrogen receptor, p53, retinoblastoma, and src gene products and clinical features with outcome..
65:117-122.
1997
-
Intratumoral heterogeneity in primary breast carcinoma: study of concurrent parameters..
64:280-287.
1997
-
Long-term results of therapy for stage C neuroblastoma..
63:172-178.
1996
-
Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?.
63:41-45.
1996
-
Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer..
60:122-127.
1995
-
Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas..
57:143-151.
1994
-
Intraportal injection of monoclonal antibody in nude mice bearing hepatic metastases..
54:71-77.
1993
-
Flow cytometric DNA analysis of interleukin-2 responsive renal cell carcinoma..
53:252-255.
1993
-
A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum: a Radiation Therapy Oncology Group (RTOG) study..
53:20-29.
1993
-
Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth..
50:161-167.
1992
-
Endobronchial interstitial Au-198 implantation in the treatment of recurrent bronchogenic carcinoma..
49:213-219.
1992
-
p53 alterations in all stages of breast cancer..
48:260-267.
1991
-
Proliferation index in various stages of breast cancer determined by Ki-67 immunostaining..
48:11-20.
1991
-
Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa..
47:117-120.
1991
-
Acral melanoma: a review of 185 patients with identification of prognostic variables..
45:91-98.
1990
-
Effects of hyperthermia and irradiation on the growth of mouse melanoma tumors following immunotherapy..
44:256-259.
1990
-
Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells..
43:67-72.
1990
-
Surgery in patients with unsuspected pheochromocytomas..
41:65-69.
1989
-
Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients..
39:139-147.
1988
-
Biochemical and ultrastructural differences between muco-epidermoid and carcinoid tumors of the bronchus..
37:227-231.
1988
-
Plasma proteins as indices of response to nutritional therapy in cancer patients..
29:160-165.
1985
-
Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5..
23:205-211.
1983
-
Human melanoma growth in the peritoneal cavity of the athymic mouse--a model for in vivo study of cell-mediated immunity..
17:309-320.
1981
-
In vivo evaluation of cell mediated immunity against human melanoma..
17:263-278.
1981
-
Influence of mouse hepatitis virus on the growth of human melanoma in the peritoneal cavity of the athymic mouse..
17:327-339.
1981
-
Characterization of melanoma cell membrane tumor-associated antigens using xenoserum, alloserum, and autoserum: I. immunofluorescence..
14:367-377.
1980
-
Non-specific and specific active immunotherapy in a B16 murine melanoma system..
12:87-96.
1979
-
Production and secretion of proteolytic enzymes by normal and neoplastic cells..
11:275-282.
1979
-
Establishment of a nude mouse model of hepatic metastasis for evaluation of targeted retroviral gene delivery: Commentary.
82:131.
2003
-
Patterns of recurrence of colorectal cancer.
2008